Tyrone Miller, DO
Payments from drug & device makers
Across 252 payments — averaging $156.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$12K
- Acell, Inc.$11K
- Endologix LLC$9K
- Silk Road Medical, Inc.$1K
- Cardiovascular Systems Inc.$1K
- Bard Peripheral Vascular, Inc.$803
- plus $4K from 33 others
What the payments were for
- Consulting fees$3,90010%
- Travel & lodging$1,9255%
- Food & beverage$10,19526%
- Education$13,89535%
- Other$9,40024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 9 | $12,012 |
| Acell, Inc. | 10 | $11,357 |
| Endologix LLC | 25 | $8,922 |
| Silk Road Medical, Inc. | 21 | $1,308 |
| Cardiovascular Systems Inc. | 46 | $1,137 |
| Bard Peripheral Vascular, Inc. | 17 | $803 |
| Inari Medical, Inc. | 17 | $598 |
| W. L. Gore & Associates, Inc. | 14 | $501 |
| Shockwave Medical, Inc | 11 | $382 |
| Johnson & Johnson(2 entities) | 15 | $352 |
| Medtronic(2 entities) | 6 | $343 |
| Intuitive Surgical | 1 | $224 |
| Abbott | 4 | $148 |
| My01 Inc. | 1 | $143 |
| Stryker | 1 | $137 |
| Neuros Medical, Inc. | 5 | $93 |
| Smith+Nephew | 4 | $77 |
| Boston Scientific | 3 | $69 |
| Lemaitre Vascular, Inc. | 3 | $66 |
| Cook Medical LLC | 5 | $63 |
| Cardiva Medical, Inc. | 3 | $52 |
| Heron Therapeutics, Inc. | 3 | $50 |
| Artivion, Inc. | 2 | $48 |
| Polynovo North America LLC | 3 | $47 |
| Pfizer | 3 | $47 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $45 |
| Teleflex LLC | 2 | $41 |
| TELA Bio, Inc. | 2 | $33 |
| Surmodics, Inc. | 2 | $28 |
| Philips North America LLC | 2 | $27 |
| Convatec Inc. | 2 | $24 |
| Acera Surgical, Inc. | 1 | $24 |
| BD | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Inspiremd Ltd | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $15 |
| Misonix Inc | 1 | $14 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$8,800
- Alto Abdominal Stent Graft System$4,284
- Ovation$3,562
- Auryon Laser System 100-120 Vac$3,000
- ENROUTE Transcarotid Neuroprotection System$999
- ALTO$931
- ENROUTE Transcarotid Stent System$880
- ENHANCE Transcarotid Peripheral Access Kit$880
- ENROUTE 0.014 Guidewire$880
- AFX2 Bifurcated Endograft System$556
- Peripheral Orbital Atherectomy System$444
- Da Vinci Surgical System$224
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$166
- EVLT$160
- MY01 Continuous Compartmental Pressure Monitor$143
- SPY-PHI SYSTEM$137
- FLOWTRIEVER CATHETER, S$134
- CT THROMBECTOMY SYSTEM KIT$134
- ENROUTE Transcarotid Stent$119
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$118
How this compares
$39,315 in reported general payments places this provider in the 90th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 21 | $12,066 |
| ClopidogrelClopidogrel Bisulfate | 245 | $1,902 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $487 |
| Atorvastatin Calcium | 37 | $105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $352 | $12,06621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,830 surgery providers in Texas.
Other surgery in Tyler
- Funda MericHouston$20.6M
- Michael HarkinsTomball$2.7M
- Lloyd StegemannCorpus Christi$1.9M
- Douglas StoddardAustin$1.4M
- Erik WilsonBellaire$1.2M
- Thomas SerenaShenandoah$1.2M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$924K
- Isidoro WienerHouston$850K
- Andy HawthorneRound Rock$843K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.